Concepedia

Rafia Bhore

RB

46

Publications

10.5K

Citations

28

H-Index

2009

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Regeneron (United States)

The University of Texas Southwestern Medical Center

Cornell University

Rafia Bhore is an author at Bristol-Myers Squibb (United States) specializing in medicine, clinical trials, and oncology.

Top concepts

Publications per year

2009–2024

46

Publications

46

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González et al. · New England Journal of Medicine · 2017 · 5.3K citations · Full text

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

David M. Weinreich, Sumathi Sivapalasingam, Thomas Norton et al. · New England Journal of Medicine · 2020 · 1.8K citations · Full text

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials

Dirk Schadendorf, Jedd D. Wolchok, F. Stephen Hodi et al. · Journal of Clinical Oncology · 2017 · 438 citations

, , +14

Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method

Amit G. Pandya, Linda S. Hynan, Rafia Bhore et al. · Journal of the American Academy of Dermatology · 2010 · 312 citations · Full text

, , +5

Risk Factors in Children Hospitalized With RSV Bronchiolitis Versus Non–RSV Bronchiolitis

C. García García, Rafia Bhore, Alejandra Soriano‐Fallas et al. · PEDIATRICS · 2010 · 293 citations · Full text

Rows per page

1–5 of 46